Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

NOTICE OF EXTRAORDINARY GENERAL MEETING OF M.O.B.A. NETWORK AB (publ)

The shareholders of M.O.B.A. Network AB (publ) (the ”Company”), reg. no 559144-3964, are hereby invited to the Extraordinary General Meeting on Monday, June 7 2021. To counteract the spread of covid-19, the Board of Directors has decided that the Extraordinary General Meeting shall be conducted without the physical presence of shareholders, representatives, or outsiders and that the shareholders before the meeting shall have the opportunity to exercise their voting rights by post. RIGHT TO ATTEND The general meeting Shareholders who wish to participate in the meeting shall: i. be

M.O.B.A. Network AB (publ) carries out directed new issues of approximately SEK 110 million to finance the acquisition of Magic Find

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE. INSIDER INFORMATION: The Board of M.O.B.A. Network AB (publ) ("MOBA Network" or "the Company") has based on the existing mandate granted by the Annual General Meeting held on

Cantargia reports positive results in ongoing phase IIa clinical trial in pancreatic cancer using nadunolimab and chemotherapy

Cantargia AB today announced positive results from the ongoing CANFOUR trial investigating nadunolimab (CAN04) in combination with gemcitabine/nab-paclitaxel (Abraxane[®]) for first line treatment of patients with advanced pancreatic cancer (PDAC). The efficacy analysis included 33 patients. Overall, the efficacy compares favorably to historical control data. Median iPFS was 7.8 months and other notable findings include five patients with durable benefit beyond initial progression (pseudoprogression), and an additional nine patients with confirmed partial response with a median duration of

Oncopeptides presents clinical abstracts on melflufen at the 2021 American Society of Clinical Oncology

STOCKHOLM — May 19, 2021 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today announces that three abstracts with data on melflufen (INN melphalan flufenamide) in relapsed refractory multiple myeloma, RRMM, have been accepted by the 2021 American Society of Clinical Oncology, ASCO, and have now been published online. The clinical data presentations include updates on Oncopeptides’ ANCHOR and LIGHTHOUSE studies as well as a pooled analysis of the O-12-M1 and HORIZON studies in

Zalaris ASA acquires ba.se. GmbH to strengthen payroll and HR BPO for the retail industry

Zalaris ASA has agreed to acquire ba.se. service & consulting GmbH (“ba.se”), a leading provider of payroll and related HR services to the retail industry in Germany.ba.se had revenue of EUR 6.1 million for the year ended 30 September 2020. The transaction will be financed from available cash, and is expected to be accretive already in 2021. The purchase price consists of an up-front payment and a performance-based element. The transaction will close in Q2 2021, but will have key milestones for performance during the period 2021 to 2023. The deal joins two leading providers of payroll

CELLINK has entered into an agreement to acquire Nanoscribe, a market leading 3D bioprinting company based on Two-Photon Polymerization technology

CELLINK AB (publ) ("CELLINK") has entered into an agreement with the shareholders of Nanoscribe Holding GmbH ("Nanoscribe"), a market leading and award-winning German company focusing on development of high-precision 3D printers based on Two-Photon Polymerization technology (“2PP”), to acquire all outstanding shares on a cash- and debt-free basis, and under the assumption that the working capital at closing equals the normalized working capital, to a purchase price of €34 million and approximately €16 million in earn-outs, in Nanoscribe (the "Acquisition"). Approximately thirty-five percent

Salmon Evolution Holding ASA: Minutes of Annual General Meeting

Salmon Evolution Holding ASA (“Salmon Evolution” or the “Company”) has today held the 2021 annual general meeting (“AGM”) as called for on 4 May 2021. All resolutions were made in accordance with the proposals set out in the AGM notice, including a change of the Company’s name to Salmon Evolution ASA. Complete minutes from the AGM are attached to this notice and are also available on the Company’s website www.salmonevolution.no. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.

New grants for early career researchers: applications open  1 August

The International Society for Research in Human Milk and Lactation and the Family Larsson-Rosenquist Foundation are recharging their annual grant offering for researchers who wish to enter or advance a career in human milk and lactation.TEP 2.0, the next generation of their Trainee Expansion Program (TEP) , offers a total of USD $1.25 million over five years, through two types of grant: Trainee Travel Fund (TTF) grants – up to USD $10,000 over up to three months to gain a new skill or experience in a different setting.   Trainee

MUSTI GROUP PLC: Share Repurchase 19.5.2021

Musti Group Stock Exchange Release 19.5.2021 MUSTI GROUP PLC: Share Repurchase 19.5.2021 In the NASDAQ OMX Helsinki Trade date           19.5.2021Bourse trade         BuyShare                  MUSTIAmount             10 000 SharesAverage price/ share    30,2119 EURTotal cost            302 119,00 EUR Company now holds a total of 140 000 sharesincluding the shares repurchased on 19.5.2021 On behalf of Musti Group Nordea Bank Finland Plc Janne Sarvikivi

YIT is carrying out earthworks for the expansion of Northvolt's facility in Sweden

YIT and Northvolt Ab have signed an agreement regarding earthworks in Northvolt's facility in Sweden. The value of the contract is approximately EUR 39 million, and it will be booked in the order book of the second quarter of the year.  For further information, please contact:  Lars Stendius, Senior Vice President, Infrastructure, Sweden, tel. + 46 703 951 040, lars.stendius@yit.se Tommi Järvenpää, Vice President, Investor Relations, YIT Corporation, tel. +358 (0)40 576 0288, tommi.jarvenpaa@yit.fi  YIT CORPORATION   Tommi Järvenpää Vice President, Investor Relations

Notice of Annual General Meeting in K-Fast Holding AB

The Annual General Meeting (“AGM”) of the shareholders in K-Fast Holding AB was held on Wednesday 19 May 2021. Against the background of the ongoing Covid-19 pandemic and to reduce the spread of infection, the AGM was held in the form of a postal ballot with no in-person representation, on the basis of temporary legislation.The AGM approved the following main resolutions in accordance with the proposals presented. Adoption of the Income Statement and Balance SheetThe AGM adopted the Income Statement and Balance Sheet of the Parent Company and Consolidated Income Statement, Consolidated

M.O.B.A. Network AB (publ) announces its intention to carry out directed share issues of approximately SEK 110 million as part of the financing of the acquisition of Magic Find

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE.  INSIDER INFORMATION: M.O.B.A. Network AB (publ) ("MOBA Network" or "the Company") has mandated ABG Sundal Collier AB to evaluate the market conditions for carrying out directed

M.O.B.A. Network enters into an agreement to acquire the company Magic Find - a leading player within gaming streaming on YouTube and owner of a number of well-known gaming communities

Stockholm, 19 May 2021 INSIDER INFORMATION: M.O.B.A. Network AB (“M.O.B.A.” or “the Company”) acquires 100 percent of the shares (the “Acquisition”) in the US company Magic Find Inc (“Magic Find”), which operates a leading Multi Channel Network (“MCN”) for streaming within gaming on YouTube as well as a number of well-known gaming community brands. The acquisition is transformative and in line with the Company's strategy to broaden the revenue base, enter into the streaming vertical and to grow with communities in new games. In 2020, the YouTube network had over 20 billion views and the

Dometic launches DeliBox, a game-changing solution for food delivery

Mobile living expert Dometic aims to disrupt the premium delivery market with a new smart food delivery solution, DeliBox. An industry-first product, the Dometic DeliBox fills a white space across a variety of markets and is poised to change the future of food delivery.Dometic, a global leader in mobile living solutions, announces the launch of its industry-first DeliBox delivery solution. This revolutionary smart delivery box is designed to preserve the quality and temperature of food or other perishables seamlessly throughout the delivery process. A groundbreaking innovation, the Dometic

#21-170 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

The joint venture of YIT and Kreate have won the bridge works for Crown Bridges project

The City of Helsinki has chosen Kruunusillat joint venture to construct the bridges in the Crown Bridges project. Kruunusillat is a joint venture of YIT and Kreate Oy. The total value of the contract is approximately EUR 123 million, of which YIT’s share is approximately EUR 61,5 million. There is a EUR 3 million option which the City of Helsinki will decide later. The contract will be booked in the order book after the two week long appeal period. The work will start in the fall 2021 and is expected to be completed in 2025. The joint venture will construct the longest bridge in Finland,

Insr: Minutes from General Meeting held

Insr Insurance Group ASA today, May 19th, 2021, held an Annual General Meeting. All proposals to the General Meeting were approved as proposed by the Board of Directors. The minutes from the General Meeting are attached to this release and available on https://www.insr.io/investor-relations/.  For further information, please contact:Hans Petter Madsen, CFOT: +47 901 57 505E: investorrelations@insr.io   Insr Insurance Group ASA was established in 2009 and listed on the Oslo Stock Exchange, with headquarters in Oslo.The company’s main task and focus going forward are to

#21-169 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Photocure ASA: Final grant of conditional share options

Oslo, Norway, 19 May 2021: Reference is made to the stock exchange release by Photocure ASA ("Photocure" or the "Company") (OSE: PHO) published on 15 September 2021 regarding 370,000 share options granted conditionally.The board of directors in Photocure ASA has today decided to convert a total of 370,000 conditional share options to unconditional share options. Of the total share option conversion, the following unconditional share options were converted for primary insiders: · Dan Schneider, CEO, has received 60,000 share option, new total holding of share options 210,000 ·

TePe wins the Sustainability Award by the ADIA

TePe Australia has been awarded the Energy Australia sustainability Program Award in 2021 by the Australian Dental Industry Association.Anne-Kristin Ottosson, General Manager of TePe Australia & NZ, said, ‘We are delighted to be recognised by the Australian Dental Industry Association for the sustainability program award. Sustainability at TePe doesn’t only mean producing an environmentally friendly product. It means taking a holistic approach ensuring social, economical as well as environmental well-being.  As a company built on health awareness and education, we see it as our

Eurocine Vaccines´ Adjuvant Technology Endocine™ is evaluated with a vaccine candidate against COVID-19

Eurocine Vaccines has signed a Material Transfer Agreement regarding the evaluation of Endocine™ together with a vaccine candidate against COVID-19.Eurocine Vaccines has signed an evaluation agreement, a Material Transfer Agreement, with an innovative, North American, small public company, regarding the evaluation of Endocine™ together with a vaccine candidate against COVID-19. Studies in one or two animal species will be conducted to study both potency and safety. Endocine™ is Eurocine Vaccines' proprietary adjuvant platform based on natural lipid compounds and formulated as a liposomal

Kojamo plc's offering of EUR 350 million green bond successfully priced under its EMTN programme

Kojamo Plc Stock Exchange Release 19 May 2021, at 5:30 p.m. EESTKojamo plc's offering of EUR 350 million green bond successfully priced under its EMTN programme NOT FOR PUBLISHING OR DISTRIBUTION, WHETHER IN WHOLE OR IN PART, EITHER DIRECTLY OR INDIRECTLY IN THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, OR IN ANY OTHER COUNTRIES WHERE PUBLICATION OR DISTRIBUTION WOULD BE AGAINST THE LAW Kojamo plc has successfully priced the offering of EUR 350 million senior unsecured green notes (the “Notes”) under its EMTN programme. The maturity of

There are no items matching the current filter
There are no more items matching the current filter
Back to top